Treating Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in the Czech Republic: Cost-Effectiveness of IDegLira Versus iGlarLixi.

Johannes PöhlmannMonika Russel-SzymczykPavel HolíkKarel RychnaBarnaby Hunt

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2019)

Novo Nordisk. Plain language summary is available for this article.

Keyphrases